| 1/3 | US=84 / Biol/Mol López-Casillas F, Vilchis-Landeros MM, Esparza-López J, Ponce-Castañeda MV, Velasco-Loyden NG, Juárez P, Montiel JL, Mendoza V. TGF-B superfamily members in normal and tumor biology: regulation of the transforming growth factor-B superfamily by betaglycan. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 451-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B TIPO III RECEPTOR; TGF-B; TGF-B INIBIDORES; TUBERCULOSE; BETAGLICAM; BETAGLICAM NULOS RATOS; ECOTODOMAIN DERRAMAMENTO; DESENVOLVIMENTO CABECA; INIBINA; NEFROPATIAS; XENOGRAFS TUMORAIS |
| 2/3 | US=84-A / Biol/Mol De Crescenzo G, Chao H, Zwaagstra J, Durocher Y, O'Connor-McCourt MD. Development of inhibitors of transforming growth factor-B signaling for therapy: engineering TGB-B traps: artificially dimerized receptor ectodomains as high-affinity blockers of TGF-B action. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 671-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; ANTAGONISTA; BETAGLICAM; ARMADILHA LIGANTE; RECEPTOR ECTODOMINIO |
| 3/3 | US=84-A / Biol/Mol Bandyópadhyay A, Sun L. Development of inhibitors of transforming growth factor-B signaling for therapy: soluble TGF-B type III receptor suppresses malignant progression of human cancer cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 723-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ANGIOGENESE; METALOPROTEINASE DE MATRIZ-9; METASTASE PULMONAR; METASTASE OSSEA; BETAGLICAM SOLUVEL; TGF-B; TGF-B TIPO DE INIBIDORES DO RECEPTOR III; TUMORIGENESE |